Hsbc Holdings PLC Rigel Pharmaceuticals Inc Transaction History

Hsbc Holdings PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.12 - $1.57 $71,369 - $100,045	63,723 Added 301.96%	84,826 $125,000
Q3 2023 Nov 13, 2023	BUY	$1.07 - $1.39 $140 - $182	131 Added 0.62%	21,103 $22,000
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $26,215 - $41,944	20,972 New	20,972 $27,000
Q2 2021 Aug 13, 2021	SELL	$3.09 - $4.54 $243,563 - $357,856	-78,823 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.35 - $4.93 $380,640 - $560,166	-113,624 Reduced 59.04%	78,823 $269,000
Q4 2020 Feb 12, 2021	SELL	$2.35 - $3.74 $7 - $11	-3 Reduced -0.0%	192,447 $673,000
Q3 2020 Nov 12, 2020	SELL	$1.78 - $4.13 $42,954 - $99,665	-24,132 Reduced 11.14%	192,450 $465,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $85,412 - $124,180	60,576 Added 38.83%	216,582 $396,000
Q1 2020 May 15, 2020	BUY	$1.27 - $3.0 $779 - $1,842	614 Added 0.4%	156,006 $243,000
Q4 2019 Feb 14, 2020	SELL	$1.6 - $2.43 $27,688 - $42,051	-17,305 Reduced 10.02%	155,392 $336,000
Q3 2019 Nov 14, 2019	BUY	$1.63 - $2.62 $265,106 - $426,122	162,642 Added 1617.52%	172,697 $323,000
Q2 2019 Aug 13, 2019	SELL	$2.02 - $2.61 $2,106 - $2,722	-1,043 Reduced 9.4%	10,055 $26,000
Q1 2019 May 15, 2019	BUY	$2.0 - $2.65 $22,196 - $29,409	11,098 New	11,098 $29,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.